Stay updated on Venetoclax & AMG 176 in Hematologic Malignancies Clinical Trial
Sign up to get notified when there's something new on the Venetoclax & AMG 176 in Hematologic Malignancies Clinical Trial page.

Latest updates to the Venetoclax & AMG 176 in Hematologic Malignancies Clinical Trial page
- Check5 days agoChange DetectedA new revision entry v3.3.4 was added to the history, and the previous revision v3.3.3 was removed.SummaryDifference0.1%

- Check12 days agoNo Change Detected
- Check19 days agoNo Change Detected
- Check26 days agoChange DetectedRevision: v3.3.3 was added to the Record History; HHS Vulnerability Disclosure and Revision: v3.3.2 were removed from the footer. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.2%

- Check48 days agoChange DetectedThe Record History shows minor version updates: addition of Revision: v3.3.2 and deletion of Revision: v3.3.1; To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%

- Check55 days agoChange DetectedA new revision entry v3.3.1 is added to the Record History and the previous v3.2.0 entry is removed.SummaryDifference0.1%

- Check62 days agoChange DetectedThe government funding and operating status banner was removed. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.7%

- Check76 days agoChange DetectedThe Record History page shows multiple version updates, including changes to Study Status and Study Design, and modifications to Contacts/Locations over time. These updates reflect ongoing adjustments to the trial record.SummaryDifference0.1%

Stay in the know with updates to Venetoclax & AMG 176 in Hematologic Malignancies Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Venetoclax & AMG 176 in Hematologic Malignancies Clinical Trial page.